We are monitoring the impact of COVID-19 on APAC Nuclear Medicine Radiopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 107
Share on
Share on

Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Research Report - By Diagnostics, By Therapeutics, By Application, By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 107
Pages: 145

APAC Nuclear Medicine Radiopharmaceuticals Market Size & Growth (2019 - 2024)

The Asia-pacific market for Nuclear Medicine Radiopharmaceuticals is estimated at $1.25 billion in 2019 and is expected to reach $2.43 billion by 2024, growing at a CAGR of 14.3%.

Key Market Dynamics:

Increasing incidences of cancer diseases and cardiovascular problems is a key driving factor for the market to grow. Rising geriatric population is one of the factors propelling the demand of the nuclear medicine radiopharmaceuticals market in the Asia Pacific. Growing focus on the development of new drugs in radiopharmaceuticals is surging the demand of the market. In addition, improvement in treatment options such as chemotherapy and surgery for cancer diseases is lavishing the growth rate of this market in the Asia Pacific. The main advantage of nuclear medicine is its effective treatment procedure while performing targeted therapies where it only affects cancerous cells and does not disturb healthy cells in the specific area. The aforementioned attribute is escalating the growth of the market to the extent.

However, nuclear medicines have a short life span which is a major hindering factor for market growth. Fluctuations in the availability of different raw materials are slightly restraining the demand of the market. The dearth of skilled persons in performing the latest diagnostic procedures is inhibiting the growth rate of the APAC nuclear medicine radiopharmaceuticals market. Rapid changes in economic strategies may also show a negative impact on the demand of the market.

The emergence of the latest technological developments in the medical sector and also the launch of innovative products in favor of the end-users is solely to promote growth opportunities for the market. Growing disposable income, especially in urban areas, is also a common factor fueling the growth of the nuclear medicine radiopharmaceuticals market. Increasing concern towards the patient’s health condition and to evaluate the wellbeing of the patient after treatment is accelerating the demand of this market. The trend towards targeted treatment procedures which is having a high success rate is leveraging the growth of the market.

This research report segmented and sub-segmented into the following categories:

APAC Nuclear Medicine Radiopharmaceuticals Market -By Type:

  • Diagnostic Radioisotopes                 

    • SPECT    

      • Technetium-99m

      • Thallium-201

      • Gallium-67

      • Iodine-23

      • Others

    • PET         

      • Fluorine-18

      • Rubidium-82

      • Others

  • Therapeutic Radioisotopes                              

    • Beta Emitters     

      • Iodine-131

      • Yttrium-90

      • Samarium-153

      • Rhenium-186

      • Lutetium-177

    • Alpha Emitters   

      • Radium-223

    • Brachytherapy   

      • Cesium-131

      • Iodine-125

      • Palladium-103

      • Iridium-192

APAC Nuclear Medicine Radiopharmaceuticals Market - By Application:

  • Cardiology                               

  • Lymphoma                             

  • Thyroid                     

  • Neurology               

  • Oncology                 

  • Others               

By Country: India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.

Regionally, Asia Pacific is leading with dominant shares of the market from the past few years and is also to hit the highest CAGR in the coming years. India and China are among the major countries contributing the highest shares for the market growth. Increasing investments in hospitals and diagnostic centers by both private and public sectors are greatly influencing the demand of the market. Growing revenue in these countries is also ascribed to spur the growth rate of the market. Japan is following India and China in accounting for the largest shares of the market with the increasing product launches with advanced technology in the medical sector. Also, rising applications of nuclear medicine in neurology is prompting the growth rate of this market.

Top companies in the market

Major companies dominating the APAC Nuclear Medicine Radiopharmaceuticals Market analyzed in this report are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 China                                            

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                               

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  2. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  3. Asia-Pacific Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  4. Asia-Pacific Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  5. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  6. Asia-Pacific Cardiology Market By Region, From 2019-2024 (USD Million)
  7. Asia-Pacific Lymphoma Market By Region, From 2019-2024 (USD Million)
  8. Asia-Pacific Thyroid Market By Region, From 2019-2024 (USD Million)
  9. Asia-Pacific Neurology Market By Region, From 2019-2024 (USD Million)
  10. Asia-Pacific Oncology Market By Region, From 2019-2024 (USD Million)
  11. Asia-Pacific Other Applications Market By Region, From 2019-2024 (USD Million)
  12. Asia-Pacific Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  13. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  14. Asia-Pacific PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  15. Asia-Pacific Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  16. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  17. Asia-Pacific Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  18. Asia-Pacific Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  19. Asia-Pacific Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  20. Asia-Pacific Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  21. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  22. Asia-Pacific PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  23. Asia-Pacific Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  24. Asia-Pacific Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  25. Asia-Pacific Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  26. Asia-Pacific Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  27. Asia-Pacific Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  28. Asia-Pacific Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  29. Asia-Pacific Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  30. Asia-Pacific Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  31. Asia-Pacific Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  32. Asia-Pacific Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  33. Asia-Pacific Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  34. Asia-Pacific Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  35. Asia-Pacific Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  36. Asia-Pacific Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  37. Asia-Pacific Radium-223 Market By Region, From 2019-2024 ( USD Million )
  38. Asia-Pacific Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  39. Asia-Pacific Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  40. Asia-Pacific Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  41. Asia-Pacific Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  42. Asia-Pacific Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  43. Asia-Pacific Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  44. China Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  45. China Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  46. India Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  47. India Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  48. Japan Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  49. Japan Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  50. South Korea Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  51. South Korea Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  52. China Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  53. India Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  54. Japan Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  55. South Korea Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  56. China SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  57. India SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  58. Japan SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  59. South Korea SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  60. China PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  61. India PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  62. Japan PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  63. South Korea PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  64. China Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  65. India Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  66. Japan Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  67. South Korea Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  68. China Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  69. India Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  70. Japan Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  71. South Korea Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  72. China Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  73. India Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  74. Japan Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  75. South Korea Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  76. China Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  77. India Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  78. Japan Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  79. South Korea Brachytherapy Market By Type, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample